Articles
News, editorials, patient stories, and more.
This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or a qualified healthcare provider before making any health decisions. Full Disclaimer
Blog
How to Get the Most Out of a 15-Minute Doctor's Appointment With a Chronic Illness
Fifteen minutes is not a lot of time, especially when you're managing a complex chronic illness with multiple symptoms, multiple medications...
Read More — How to Get the Most Out of a 15-Minute Doctor's Appointment With a Chronic Illness »
Blog
What Is a Flare, Really?
The word "flare" gets used constantly in autoimmune communities, but it rarely gets a clear definition. If you've been told your disease is...
Read More — What Is a Flare, Really? »Subcutaneous TEPEZZA Hits the Mark in Phase 3 Trial for Thyroid Eye Disease
Amgen announced that a subcutaneous, on-body injector version of TEPEZZA met its primary and key secondary endpoints in a Phase 3 trial for...
Read More — Subcutaneous TEPEZZA Hits the Mark in Phase 3 Trial for Thyroid Eye Disease »
Blog
Working from Home with Autoimmune Disease: Gear That Helps Me Stay Productive and Comfortable
Living with an autoimmune disease often means navigating fatigue, joint pain, brain fog, and other unpredictable symptoms. But that doesn’...
Read More — Working from Home with Autoimmune Disease: Gear That Helps Me Stay Productive and Comfortable »Phase 3 VALOR Trial Published in NEJM: Brepocitinib Delivers Landmark Results in Dermatomyositis
The Phase 3 VALOR trial, published in the New England Journal of Medicine, found that brepocitinib 30 mg significantly outperformed placebo...
Read More — Phase 3 VALOR Trial Published in NEJM: Brepocitinib Delivers Landmark Results in Dermatomyositis »FDA Grants Fast Track Status to Allogene’s Autoimmune Therapy
FDA fast track designation highlights potential new cell therapy for autoimmune diseases.
Read More — FDA Grants Fast Track Status to Allogene’s Autoimmune Therapy »All 10 Evaluable Patients Achieve Insulin Independence in Eledon's Type 1 Diabetes Islet Transplant Trial
Updated results from UChicago Medicine show that all 10 evaluable patients who received islet transplants supported by tegoprubart achieved...
Read More — All 10 Evaluable Patients Achieve Insulin Independence in Eledon's Type 1 Diabetes Islet Transplant Trial »COVID-19 and Hashimoto's: New Research Points to a Troubling Link
New clinical data from China suggests COVID-19 may trigger the onset of Hashimoto's thyroiditis in people with no prior thyroid history. If...
Read More — COVID-19 and Hashimoto's: New Research Points to a Troubling Link »A New Blood Test Could Cut the Nine-Year Diagnostic Wait for Ankylosing Spondylitis
Augurex Life Sciences has developed SPINEstat, a novel blood test that measures anti-14-3-3eta autoantibodies to distinguish inflammatory ba...
Read More — A New Blood Test Could Cut the Nine-Year Diagnostic Wait for Ankylosing Spondylitis »Inside the Inflamed Eye: A 2026 Review Explains How Autoimmune Uveitis Begins and How to Treat It
A comprehensive review published in Frontiers in Medicine traces the immune mechanisms behind autoimmune uveitis, one of the leading causes...
Read More — Inside the Inflamed Eye: A 2026 Review Explains How Autoimmune Uveitis Begins and How to Treat It »New Clinical Trial Explores Targeted Treatment for Myasthenia Gravis
New clinical trial investigates targeted immune therapy for myasthenia gravis.
Read More — New Clinical Trial Explores Targeted Treatment for Myasthenia Gravis »Cell Therapy for Sjögren's Disease Dry Mouth Earns FDA Fast Track Designation
Researchers at the University of Wisconsin are testing a novel cell therapy for dry mouth caused by Sjögren's disease. The FDA has granted...
Read More — Cell Therapy for Sjögren's Disease Dry Mouth Earns FDA Fast Track Designation »